In contrast to DCM group, patients with AS were not associated with downregulation of enhancer derived lncRNA Novlnc6, or its predicted target gene NKX2–5 (NK2 Transcription Factor Related, Locus 5). The gene discussed is NKX2-5; the disease is familial dilated cardiomyopathy.